CDK4/6-IN-15 is an orally available and selective CDK4/6 inhibitor used to effectively inhibit cancer cell growth; it arrests the cell cycle at the G1 phase and suppresses phosphorylation of the retinoblastoma tumor suppressor protein (Rb) at the S780 site as well as E2F-regulated gene expression.